Day One Biopharmaceuticals, Inc.DAWNNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank67
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-32.83%
↑ 62% vs avg
Percentile
P67
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-86.38%
Historical baseline
PeriodValue
2025-32.83%
202446.81%
2023-33.66%
2022-126.36%
2021-259.84%
2020-198.76%
20190.00%